[HTML][HTML] Changes in utilization and discard of hepatitis C–infected donor livers in the recent era
The impact of interferon (IFN)-free direct-acting antiviral (DAA) hepatitis C virus (HCV)
treatments on utilization and outcomes associated with HCV-positive deceased donor liver
transplantation (DDLT) is largely unknown. Using the Scientific Registry of Transplant
Recipients, we identified 25 566 HCV-positive DDLT recipients from 2005 to 2015 and
compared practices according to the introduction of DAA therapies using modified Poisson
regression. The proportion of HCV-positive recipients who received HCV-positive livers …
treatments on utilization and outcomes associated with HCV-positive deceased donor liver
transplantation (DDLT) is largely unknown. Using the Scientific Registry of Transplant
Recipients, we identified 25 566 HCV-positive DDLT recipients from 2005 to 2015 and
compared practices according to the introduction of DAA therapies using modified Poisson
regression. The proportion of HCV-positive recipients who received HCV-positive livers …